TABLE 4.
CSF analysis results by tumor type and grade in dogs with glioma 5
Tumor type and grade a | Elevated TP concentration b | Elevated TNCC c | ACD d | Normal CSF a | Mean TP concentration and range (mg/dL) | Mean TNCC and range (cells/μL) | Differential cytology |
---|---|---|---|---|---|---|---|
LO (3) | 1 (2) | 1 (3) | 1 (2) | 1 (2) | 23.3 (20‐26.5) | 28 (1‐81) | Eosinophilic pleocytosis, 1 e |
HO (13) | 8 (11) | 3 (13) | 6 (11) | 3 (11) | 143.0 (10.1‐780) | 38 (0‐460) | Increased percentage of neutrophils (62%), 1 f ; Mixed cell pleocytosis, 3 g |
HA (4) | 3 (4) | 3 (4) | 0 (4) | 1 (4) | 206.1 (22.5‐736) | 15 (0‐27) | Mixed cell pleocytosis, 3 |
HU (3) | 1 (2) | 1 (3) | 0 (2) | 1 (2) | 75.1 (20‐130.2) | 10 (0‐27) | Neutrophilic pleocytosis, 1 h |
Abbreviations: ACD, albuminocytologic dissociation; CSF, cerebrospinal fluid; HA, high‐grade astrocytoma; HO, high‐grade oligodendroglioma; HU, high‐grade undefined glioma; LO, low‐grade oligodendroglioma; TNCC, total nucleated cell count; TP, total protein.
Number of cases in which CSF information was available.
Number of cases with >25 mg/dL TP concentration (number of cases with available information).
Number of cases with >5 cells/μL (number of cases with available information).
Number of cases with >25 mg/dL TP concentration and <5 cells/μL (number of cases with available information).
Defined as CSF with >50% eosinophils.
Defined as CSF >2% nondegenerated neutrophils. 35
Defined as CSF with a mixture of mostly lymphocytes and large mononuclear cells and >20% contribution of neutrophils and, occasionally, eosinophils. 35
Defined as CSF with >75% neutrophils.